Skip to main content
. 2021 Jul 6;9(1):619–635. doi: 10.1080/21642850.2021.1948416

Figure 1.

Figure 1

. Frequencies of participants’ responses for 16D (panels A-B), and 17D (panels C-D) individual items and options in 2 groups with Primary Immunodeficiency (PID) (n = 48) and survivors of Acute Lymphoblastic Leukemia (ALL) (n = 153). Note. Panel A Frequencies for 16D individual items for ALL. Panel B Frequencies for 16D individual items for PID. Panel C Frequencies for 17D individual items for ALL. Panel D Frequencies for 17D individual items for PID. Levels 1 to 5 refer to levels of impairment of function. Level 1: no impairment, Level 5: severe impairment. Frequency tables of individual responses to each item are available in supplementary material to this article.